{
    "Orphapacket": {
        "ORPHApacketId": "217093",
        "creationDate": "2025-06-26 11:48:15",
        "version": "1.3.42 / 4.1.8 [2025-03-03]",
        "copyright": "Orphanet (c) 2025",
        "ORPHAcode": "217093",
        "Label": "Mucopolysaccharidosis type 2, attenuated form",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_217093",
        "DisorderType": {
            "value": "Clinical subtype",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377796"
        },
        "Synonyms": [
            {
                "Synonym": "Hunter syndrome type B"
            },
            {
                "Synonym": "Iduronate 2-sulfatase deficiency type B"
            },
            {
                "Synonym": "MPS2B"
            },
            {
                "Synonym": "MPSIIB"
            },
            {
                "Synonym": "Mucopolysaccharidosis type 2B"
            },
            {
                "Synonym": "Mucopolysaccharidosis type II, attenuated form"
            },
            {
                "Synonym": "Mucopolysaccharidosis type IIB"
            },
            {
                "Synonym": "Mucopolysaccharidosis type 2, slowly progressive form"
            },
            {
                "Synonym": "Mucopolysaccharidosis type 2, non-neuropathic form"
            }
        ],
        "ExternalReferences": [
            {
                "Source": "OMIM",
                "Reference": "309900",
                "DisorderMappingRelation": "NTBT (ORPHAcode is narrower than the targeted code used to represent it)"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "Mucopolysaccharidosis type 2 attenuated form (MPS2att) the less severe form of MPS2 leads to a massive accumulation of glycosaminoglycans and a wide variety of symptoms including distinctive facies short stature cardiorespiratory and skeletal findings. It is differentiated from mucopolysaccharidosis type 2 severe form by the absence of cognitive decline."
        },
        "Genes": [
            {
                "Gene": {
                    "Symbol": "IDS",
                    "Name": "iduronate 2-sulfatase",
                    "ExternalReferences": [
                        {
                            "Source": "ClinVar",
                            "Reference": "IDS"
                        },
                        {
                            "Source": "HGNC",
                            "Reference": "5389"
                        },
                        {
                            "Source": "OMIM",
                            "Reference": "300823"
                        }
                    ],
                    "DisorderGeneAssociationType": "Disease-causing germline mutation(s) in"
                }
            }
        ],
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "580",
                        "Label": "Mucopolysaccharidosis type 2"
                    }
                ]
            }
        ],
        "Prevalences": {
            "Prevalence": [
                {
                    "Source": "ORPHANET",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "Unknown",
                    "ValMoy": "0.0",
                    "PrevalenceGeographic": "Worldwide"
                }
            ]
        },
        "AverageAgeOfOnsets": {
            "AverageAgeOfOnset": [
                {
                    "value": "Childhood"
                }
            ]
        },
        "TypeOfInheritances": {
            "TypeOfInheritance": [
                {
                    "value": "X-linked recessive"
                }
            ]
        }
    }
}